(1-METHYL-1H-INDAZOL-5-YL)BORONIC ACID(CAS: 590418-08-9)

Regulatory guidelines for (1-Methyl-1H-indazol-5-yl)boronic acid (CAS: 590418-08-9) include GHS classification for handling and storage, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for use in pharmaceuticals and agriculture. Ensuring compliance with these guidelines is crucial for safe handling and environmental protection.

In synthesis, alternatives to (1-Methyl-1H-indazol-5-yl)boronic acid include other boronic acids and related compounds like (1-Phenyl-1H-indazol-5-yl)boronic acid or (1-Methyl-1H-benzimidazol-2-yl)boronic acid. These alternatives can serve similar purposes in various chemical reactions, offering researchers and chemists flexible options.

The market for (1-Methyl-1H-indazol-5-yl)boronic acid is showing steady growth, driven by its applications in medicinal chemistry and drug discovery. Research trends focus on its use as a key intermediate in the synthesis of bioactive compounds and its potential in developing new therapeutic agents. Price trends indicate a stable market with minor fluctuations.

Waste containing (1-Methyl-1H-indazol-5-yl)boronic acid should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common disposal method, but environmental precautions must be taken to minimize pollution. Compliance with local waste management regulations is essential for safe and effective disposal.